TNFRSF4 and neoplasm: Another study evaluated the combination of CpG and OX40 as neoadjuvant therapy and found that tumor control and long-term immunological memory were improved when intratumoral immunotherapy was given 4 days prior to tumor resection; unexpectedly, mice that were given treatment immediately before tumor excision had significantly worse survival [15].